

Mednext Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 5.05 M
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.82 Cr
- Satisfied Charges ₹ 1.10 Cr
- Revenue Growth -3.71%
- Profit Growth 37.97%
- Ebitda 118.22%
- Net Worth 1.26%
- Total Assets 57.79%
About Mednext Pharma
Mednext Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 February 2009 and has a history of 16 years and three months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 5.05 M.
The company currently has active open charges totaling ₹19.82 Cr. The company has closed loans amounting to ₹1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Vyas and Neelam Vyas serve as directors at the Company.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110MH2009PTC190076
- Company No.
190076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Mednext Pharma Private Limited offer?
Mednext Pharma Private Limited offers a wide range of products and services, including Antihistamines, Loratadine, Skin Care Cosmetics, Sun Protection Cream, Injectable Products, Pharmaceutical Injectables, Allopathic Cough Syrup, Anti Cold Syrup, Body Cream, Anti Acne Cream.
Who are the key members and board of directors at Mednext Pharma?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anil Vyas ![]() | Director | 03-Feb-2009 | Current |
Neelam Vyas ![]() | Director | 04-Mar-2017 | Current |
Financial Performance of Mednext Pharma.
Mednext Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.71% decrease. The company also saw a substantial improvement in profitability, with a 37.97% increase in profit. The company's net worth moved up by a moderate rise of 1.26%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mednext Pharma?
In 2023, Mednext Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Mednext Biotech Limited
Anil Vyas and Neelam Vyas are mutual person
- Alice Pharma Private Limited
Anil Vyas and Neelam Vyas are mutual person
- Alice Pharma (Mumbai) Private Limited
Neelam Vyas is a mutual person
- Ceza Formulations Private Limited
Anil Vyas is a mutual person
- Tirtham Hospitality Private Limited
Anil Vyas and Neelam Vyas are mutual person
Charges (Loans)
₹19.82 Cr
₹1.10 Cr
Charges Breakdown by Lending Institutions
- Others : 16.59 Cr
- Axis Bank Limited : 2.23 Cr
- Indusland Bank Limited : 1.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
16 Mar 2022 | Others | ₹16.59 Cr | Open |
19 Feb 2016 | Axis Bank Limited | ₹2.23 Cr | Open |
16 Jan 2015 | Indusland Bank Limited | ₹1.00 Cr | Open |
21 Oct 2013 | Canara Bank | ₹1.10 Cr | Satisfied |
How Many Employees Work at Mednext Pharma?
Unlock and access historical data on people associated with Mednext Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mednext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mednext Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mednext Pharma
Recent activity within the organization
- Annual General Meeting
Mednext Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Mednext Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Charges
A charge with Others of Rs. 16.59 Cr registered on 16 Mar 2022 with Charge ID 100558565 was modified on 13 Mar 2023.
- Charges
A charge with Others amounted to Rs. 16.59 Cr with Charge ID 100558565 was registered on 16 Mar 2022.
- Charges
A charge registered on 21 Oct 2013 via Charge ID 10465501 with Canara Bank was fully satisfied on 12 Mar 2018.
- Director Appointment
Neelam Vyas was appointed as a Director was appointed as a Director on 04 Mar 2017 & has been associated with this company since 8 years 2 months .
Frequently asked questions
What is the Incorporation or founding date of Mednext Pharma Private Limited?
Mednext Pharma Private Limited was incorporated on 03 Feb 2009.
What is authorized share capital and paid-up capital of Mednext Pharma Private Limited?
The authorized share capital of Mednext Pharma Private Limited is ₹ 1.50 Cr and paid-up capital is ₹ 5.05 M.
Who are the current board members & directors of Mednext Pharma Private Limited?
Currently 2 directors are associated with Mednext Pharma Private Limited.
- Anil Kumar Vyas
- Neelam Vyas
What is the registered address of Mednext Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mednext Pharma Private Limited is Flat No. 901 Sai Anant Smit Chs Pl-12 Sect-30 Vashi, India, Navi Mumbai, Maharashtra, 410209.
What is the corporate identification number (CIN) and company number of Mednext Pharma Private Limited?
The corporate identification number (CIN) of Mednext Pharma Private Limited is U24110MH2009PTC190076 and the company number is 190076 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mednext Pharma Private Limited?
The Official website of Mednext Pharma Private Limited is https://www.mednextpharma.com
What has been the recent revenue trend for Mednext Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Mednext Pharma Private Limited has fallen by -3.71%.
What change has been observed in the net worth of Mednext Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Mednext Pharma Private Limited has experienced an upsurge of 1.26%.
What are the total open charges for Mednext Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Mednext Pharma Private Limited amount to ₹ 19.82 Cr.
When was the last Balance Sheet of Mednext Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Mednext Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Harsh BullaDirector
AF
Alex FernandesDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India